Fundraising Fox

Maha Katabi

Investor

General Partner at Sofinnova Ventures

Montreal

Writes $100K – $5M checks · typically $1.5M

About

Maha Katabi is a PhD in Pharmacology and CFA who built crossover public/private biotech investing platforms, focuses on clinical‑stage single‑asset radiopharmaceutical and targeted oncology companies, and chairs Exactis Innovation.

Invests in

BiotechHealthtechMedical Devices

Deals · 5

Marea Therapeutics, Inc.Board seat

via Sofinnova Ventures · filed Jun 2024 · $160.4M raise

Gyroscope Therapeutics LtdBoard seat

via Sofinnova Ventures · filed Apr 2021 · $148M raise

Aerovate Therapeutics, Inc.Board seat

via Sofinnova Ventures · filed Aug 2020 · $75.8M raise

Apellis Pharmaceuticals, Inc.Board seat

via Sofinnova Ventures · filed Aug 2017 · $60.1M raise

Effector TherapeuticsBoard seat

via Sofinnova Ventures · filed Feb 2016 · $56M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Sofinnova Ventures

Network1

Investors connected to Maha in public investor directories — a warm-intro map.

Frequently asked questions

Where does Maha Katabi work?
Maha Katabi is General Partner at Sofinnova Ventures.
What does Maha Katabi invest in?
Maha Katabi invests in Biotech, Healthtech, Medical Devices.
What check size does Maha Katabi write?
Maha Katabi typically writes checks of $100K – $5M.